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ABSTRACT
Although the overall level of macrolide resistance (27%) has remained stable in Portugal, a rapid
inversion in the dominant phenotypes has been noted, with a sharp decrease in the MLSB phenotype
paralleled by an increase in the M phenotype. To gain further insight into these changes, 325 macrolide-
resistant isolates were characterised using a combination of pulsed-field gel electrophoresis (PFGE) and
multilocus sequence typing (MLST). The use of Cfr9I, an isoschizomer of SmaI, to digest M phenotype
isolates that were refractory to SmaI digestion allowed direct comparison of MLSB and M isolates. The
results from PFGE and MLST were highly concordant and identified eight major clones, accounting for
92% of the isolates, each of which was associated exclusively with a single macrolide resistance
phenotype. Two major clones were found among MLSB isolates, characterised by sequence types (ST) 46
(T12 ⁄ emm22) and ST52 (T28 ⁄ emm28), whereas clones characterised by ST39 (T4 ⁄ emm4) and ST28
(T1 ⁄ emm1) dominated among M isolates. The clone defined by ST52 corresponded to a bacitracin-
resistant clone circulating in Europe, and a novel variant expressing other surface antigens (T12 ⁄ emm22)
was detected. The presence of the four major clones has been reported previously in other European
countries, suggesting Europe-wide dissemination of a few macrolide-resistant lineages.
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INTRODUCTION
Two mechanisms of resistance to macrolide anti-
biotics have been described in Streptococcus pyo-
genes: one caused by the presence of a methylase
encoded by the erm(B) or erm(A) genes that results
in resistance to most macrolides, lincosamides
and streptogramin B (the MLSB phenotype); and a
second caused by the presence of an efflux pump
encoded by the mef(A) gene that results in
resistance to 14- and 15-membered macrolides,
while susceptibility to clindamycin and streptogr-
amin B antibiotics is retained [1]. Isolates carrying
both erm and mef(A) resistance determinants
expressing either the MLSB or the M phenotype
have also been described previously [2].
Macrolide resistance is increasing among
S. pyogenes isolates in several European countries,
and this has often been accompanied by an
alteration in the prevailing phenotypes [3]. In
Portugal, macrolide resistance remained almost
constant during 1998–2003 (27%) [4], but surpris-
ingly, this was not associated with a stable
population of macrolide-resistant S. pyogenes
strains. Indeed, the predominance of the MLSB
phenotype, which accounted for c. 80% of isolates
in 1998, was completely reversed in 2003, when
76.6% of the isolates expressed the M phenotype
[4]. This change is puzzling, since there was no
significant alteration in macrolide use during this
period, and sustained use could be expected to
select for isolates expressing the MLSB phenotype,
since this phenotype is associated with higher
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resistance in vitro. One possibility is that the
introduction of a highly successful clone or
clones, particularly from neighbouring Spain,
where the M phenotype predominates (95%) [5],
could have displaced a local clone. However,
rapid changes in S. pyogenes isolates associated
with pharyngitis, not attributable readily to any
single factor, but thought to represent natural
fluctuations, have also been described previously
[6].
Comparison of the profiles generated by
pulsed-field gel electrophoresis (PFGE) has long
been used to distinguish clones of S. pyogenes [7].
The endonuclease used to generate the profiles is
frequently SmaI, but the emergence of isolates
expressing the M phenotype with DNA that is
resistant to digestion with SmaI [7] has led to the
use of alternative enzymes, often SfiI, to charac-
terise the two macrolide resistance phenotypes
[8], thereby preventing a direct comparison of the
M and MLSB clones. More recently, sequence-
based typing methods have been developed that
rely on determining the nucleotide sequences of
internal fragments of housekeeping genes [9].
These sequencing methods, known as multilocus
sequence typing (MLST), provide unambiguous
results that are easily portable and accessible in a
central database, thereby facilitating comparison
of results obtained in different laboratories.
In order to gain a better insight into the
dynamic behaviour exhibited by macrolide-resist-
ant S. pyogenes isolates in Portugal, and to clarify
the relationship of the major clones involved with
those reported from other European countries
[3,8,10], the present study characterised 325
macrolide-resistant S. pyogenes isolates from Por-
tugal [4] by PFGE, using enzymes suitable for the
direct comparison of M and MLSB isolates, and
MLST.
MATERIALS AND METHODS
Bacterial isolates
A collection of non-duplicate 325 macrolide-resistant S. pyo-
genes isolates recovered from throat swabs and associated with
a diagnosis of tonsillo-pharyngitis between 1998 and 2003 was
analysed. The isolates, provided by 30 laboratories distributed
throughout Portugal, comprised 53 from 1998, 47 from 1999, 59
from 2000, 55 from 2001, 64 from 2002, and 47 from 2003.
Results of antimicrobial susceptibility tests using CLSI (for-
merly NCCLS) interpretative criteria [11], T-typing results,
macrolide-resistant phenotypes and genotypes, and emm-
typing results, have been reported previously [4].
PFGE and MLST
Chromosomal DNA of macrolide-resistant isolates was pre-
pared with a modification of a method described previously
[12]. In brief, the composition of the lysis solution was altered
to include mutanolysin 5 U ⁄mL, lysozyme 1 mg ⁄mL and
ribonuclease A 30 lg ⁄mL (Sigma-Aldrich, Steinheim, Ger-
many). After digestion with SmaI or Cfr9I (Fermentas, Vilnius,
Lithuania), the fragments were resolved by PFGE as described
previously [12]. All MLSB isolates produced multiple bands
following digestion with SmaI; however, the DNA of most
isolates with the M phenotype (n = 150; 46.2%) did not digest
with SmaI, and in such cases the isoschizomer Cfr9I (Fermen-
tas) was used.
Bionumerics software (Applied-Maths, Sint-Martens-
Latem, Belgium) was used to create UPGMA (unweighted pair-
group method with arithmetic mean) dendrograms of the SmaI
or Cfr9I fragment patterns. The Dice similarity coefficient was
used, with optimisation and position tolerance settings of 1.0
and 1.5, respectively. PFGE clusters were defined as isolates
with ‡ 80% similarity, as described previously for Streptococcus
pneumoniae [13]. A PFGE-based cluster was considered to be a
major lineage if it included ten or more isolates, or if it
included five or more isolates recovered in the same year.
MLST analysis was performed with representatives of each
major lineage, as described previously [9], and allele and
sequence type (ST) identification were performed using the
S. pyogenes MLST database (http://spyogenes.mlst.net).
Bacitracin susceptibility testing
Bacitracin susceptibility was determined for all isolates by disk-
diffusion, using disks containing bacitracin 0.05 U (Oxoid,
Basingstoke, UK) and Tryptic Soy Agar (Oxoid), supplemented
with sheep blood 5% v ⁄v, according to the manufacturer’s
instructions. Any zone of inhibition around the bacitracin disk
was interpreted as being indicative of susceptibility.
RESULTS
PFGE and MLST
All 325 isolates included in this study were
typeable by PFGE, and 40 (12.3%) isolates
were analysed by MLST. Eight major lineages
were found, containing 297 (91.4%) of the isolates.
The PFGE patterns of representative isolates from
each major clone are shown in Fig. 1. The remain-
ing isolates were included in minor PFGE groups
(containing six or fewer isolates) or had unique
PFGE profiles. In most cases, all isolates belong-
ing to the same PFGE-defined cluster had the
same ST by MLST. For the two exceptions, the STs
were single-locus variants of each other, indica-
ting a close genetic relationship between the
isolates. Similarly, most isolates belonging to the
same PFGE cluster had the same emm type and
the same resistance phenotype and genotype. The
characteristics of the eight lineages found in this
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study, as well as their distribution during the
study period, are summarised in Table 1.
The largest cluster (cluster A; 118 (36.3%)
isolates) comprised exclusively MLSB isolates.
MLST was performed for nine of these isolates,
and all except one belonged to ST46, with the
remaining isolate belonging to ST45, which is a
single-locus variant. This cluster also included
most (n = 7) of the isolates that carried the erm(B)
and mef(A) resistance determinants simulta-
neously. These seven isolates were recovered
from two hospitals in the same region during
1998 and 1999.
Cluster B accounted for 46 (14.2%) of the
isolates (all MLSB), most of which were T28
emm28. However, a significant proportion (n = 9;
19.6%) of the isolates in this cluster had a
different T and emm type (T12 emm22). Ten
(21.8%) of these 46 isolates, representing both
T ⁄ emm combinations present in this cluster, were
analysed by MLST. All ten isolates characterised
by MLST, defined either by emm22 or emm28,
belonged to ST52.
The most heterogeneous cluster found in this
study (cluster C) accounted for 48 (14.8%) of the
isolates, all of which expressed the M phenotype.
Although almost all of these isolates were emm4,
the T types present in this cluster were very
diverse. The dominant T type was T4, but other
T types, such as 5 ⁄ 27 ⁄ 44, T6, T1, B3264, T12, T13
and T25, accounted for 34.8% of the isolates in
this cluster. Despite this diversity, three of the
four isolates analysed by MLST were ST39; the
exception, a T12 ⁄ emm4 isolate, belonged to ST38.
However, these STs are single-locus variants of
each other, supporting the overall grouping
revealed by PFGE analysis.
Isolates presenting with emm12 were divided
into two PFGE clusters (clusters D and E;
Fig. 1), but this distinction was not supported
by the other methods used. All the isolates in
these two clusters expressed the M phenotype,
and almost all had the same T type (T12).
Moreover, a single ST (ST36) was associated
with both clusters, suggesting that clusters D
and E represent subgroups of the same genetic
lineage, together accounting for 30 (9%) of the
isolates.
Cluster F (n = 35; 10.8%) included emm1 iso-
lates, all of which expressed the M phenotype.
The four isolates from this cluster that were
analysed by MLST included one with a T type
B
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Fig. 1. Pulsed-field gel electrophoresis (PFGE) analysis of
macrolide-resistant Streptococcus pyogenes isolates from
Portugal. (A) Dendrogram showing cluster analysis of
the PFGE profiles of the 325 macrolide-resistant isolates by
the unweighted pair-group with arithmetic mean
(UPGMA) method. For each of the major clones, a triangle
proportional to the number of isolates is shown in the
dendrogram, followed by the capital letter designating the
PFGE cluster. (B) PFGE profiles generated following SmaI
(A,B) or Cfr9I (C–H) digestion of DNA isolated from
representatives of each major clone. Capital letters identi-
fying each lane correspond to the clone designations. m,
lambda ladder PFGE marker (New England Biolabs,
Beverly, MA, USA).
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different from T1, namely T13, but all were found
to belong to ST28.
Two smaller PFGE clusters (clusters G and H)
included 12 and eight isolates, respectively
(Table 1).
A small proportion (n = 28; 8.6%) of isolates
did not belong to any of the clusters described
above. Five had a unique PFGE pattern, and
although the emm types of most (n = 4) of these
were represented in the major clones (i.e., emm 1,
9, 22 and 75), these isolates had diverse genetic
backgrounds.
Bacitracin susceptibility
All isolates grouped in PFGE cluster B were
resistant to bacitracin, as shown by the absence of
an inhibition zone around the bacitracin disk,
whereas the remaining 279 isolates were bacitra-
cin-susceptible.
DISCUSSION
Although the overall level of erythromycin resist-
ance remained constant during the study period,
the MIC50 for the isolates recovered during 1998
was > 512 mg ⁄L, compared with 16 mg ⁄L in 2003,
suggesting that changes had occurred in the
clonal composition of the macrolide-resistant
population. The strains analysed represented
diverse genetic lineages corresponding to 21
PFGE profiles. A large diversity among macro-
lide-resistant isolates, notably among isolates
presenting the M phenotype, is not unusual
[14,15]. Nevertheless, eight clones accounted for
most (92%) of the isolates, and the four most
frequent lineages (PFGE clusters A, B, C and F)
represented 76% of the isolates analysed. Despite
significant yearly variations, six of the major
clones identified were detected during five of
the six study years, indicating their persistence in
the population. Also noteworthy, and in agree-
ment with previous studies, was the strong
association between emm type and ST [9], as well
as between PFGE cluster and macrolide resistance
phenotype. Although the latter association has
been reported previously [16], these comparisons
were frequently incomplete because of the exist-
ence of isolates expressing the M phenotype that
were not digested by SmaI, which is the endo-
nuclease used most frequently for PFGE analysis
[8]. The data reported here confirm the above
findings for all isolates, since use of the isoschiz-
omer Cfr9I allowed direct comparison of all M
and MLSB isolates.
Most of the isolates grouped in each PFGE
cluster also shared the same emm type, with the
notable exception of cluster B, in which a signifi-
cant fraction (n = 9, 19.6%) were emm22. Although
these isolates did not form a PFGE subgroup within
cluster B, they also shared a T type (T12) that was
different from that of other isolates in cluster B, and
were indistinguishable, according to these surface
markers, from clone A. However, MLST analysis
confirmed the inclusion of these isolates in clone B,
since the T28 ⁄ emm28 and T12 ⁄ emm22 isolates
Table 1. Properties of macrolide-
resistant Streptococcus pyogenes iso-
lates from Portugal
PFGE
cluster
No. of
isolates (%) T ⁄ emm Phenotype Genotype ST
Year
1998 1999 2000 2001 2002 2003
A 118 (36.3) 12 ⁄ 22a MLSB erm(B)b 46c 44 32 17 13 7 5
B 46 (14.2) 28 ⁄ 28d MLSB erm(B)e 52 2 12 12 14 6
C 48 (14.8) 4 ⁄ 4f M mef(A) 39g 5 3 7 3 10 20
D 20 (6.2) 12 ⁄ 12h M mef(A) 36 1 4 3 5 5 2
E 10 (3.1) 12 ⁄ 12 M mef(A) 36 2 3 1 2 2
F 35 (10.8) 1 ⁄ 1i M mef(A) 28 1 5 7 16 6
G 12 (3.7) 25 ⁄ 75 M mef(A) 150 3 5 4
H 8 (2.5) 9 ⁄ 9 M mef(A) 75 6 2
Otherj 28 (8.6) M 3 3 6 11 3 2
PFGE, pulsed-field gel electrophoresis.
a13 ⁄ 22 (n = 3); 25 ⁄ 22 (n = 1).
bAlthough all isolates had the MLSB phenotype, 111 isolates carried erm(B) and seven isolates carried both erm(B)
and mef(A).
cST45 (n = 1).
d12 ⁄ 22 (n = 9).
eAlthough all isolates had the MLSB phenotype, 45 isolates carried erm(B) and one isolate carried both erm(B) and
mef(A).
fSeven other T types (5 ⁄ 27 ⁄ 44, 6, 1, B3264, 12, 13 and 25) were present, including one isolate defined by 12 ⁄ 12.
gST38 (n = 1).
h13 ⁄ 12 (n = 1); 2 ⁄ 12 (n = 1).
i13 ⁄ 1 (n = 1).
jFifteen T ⁄ emm type combinations were distributed among 13 PFGE clusters.
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shared ST52, having no alleles in common with
ST46, which is characteristic of clone A. Moreover,
all these isolates shared the unusual property of
being resistant to bacitracin, a test used tradition-
ally in the presumptive identification of S. pyogenes
[17]. The first outbreak involving macrolide-resist-
ant (MLSB) S. pyogenes isolates resistant to bacitra-
cin was described in the USA [17], but no data
regarding T and emm type are available. Recently,
macrolide- and bacitracin-resistant S. pyogenes iso-
lates with T28 ⁄ emm28 have been described in
Europe [18,19], including Spain, where these iso-
lates were associated with ST52 [20], the same ST of
the isolates found in Portugal. A report from
Sweden [21] also identified T28 ⁄ emm28 isolates
belonging to ST52 as the dominant clone among
invasive isolates; however, the macrolide and
bacitracin susceptibility of the isolates involved
was not reported. The variant reported in the
present study, sharing the same surface antigens as
the dominant MLSB clone T12 ⁄ emm22, has not been
reported previously, and perhaps resulted from
transfer of the necessary genetic determinants into
the ST52 background, as has been suggested to
account for the presence of multiple emm types
associated with the same ST [9].
The substantial temporal variations in clonal
prevalence among macrolide-resistant S. pyogenes,
as documented in Portugal [4], highlight the
pitfalls of comparing the data from various studies
conducted in Europe. Moreover, there are few
studies that have characterised the genetic back-
grounds of macrolide-resistant S. pyogenes by
MLST, and studies using PFGE frequently resort
to different endonucleases (usually SfiI) to char-
acterise M phenotype isolates. Further complica-
ting the comparison among studies is the inclusion
of isolates responsible for different types of infec-
tion, since an association between emm type and
particular disease manifestations [22] could create
a bias towards different emm types.
Despite these limitations, three surveys of STs
among macrolide-resistant S. pyogenes in Euro-
pean countries with a lower rate of macrolide
resistance than Portugal identified similar clones.
Thus, in a survey in Germany, in which isolates
with the M phenotype predominated (n = 30), the
most common clone was ST39 ⁄ emm4, with other
important clones including ST28 ⁄ emm1 and
ST36 ⁄ emm12 [10], i.e., similar to the present find-
ings in Portugal. In Poland, ST36 ⁄ emm12 accoun-
ted for three of five isolates expressing the M
phenotype [3]. However, in both Germany and
Poland, isolates expressing the MLSB phenotype
carried the erm(A) gene, unlike the situation in
Portugal, and the few isolates carrying the erm(B)
gene were unrelated to the major clones identified
in Portugal. It is noteworthy that three of the four
isolates from Portugal with an inducible MLSB
phenotype shared the same emm gene as one of the
dominant clones expressing this phenotype in both
Poland and Germany (ST63 ⁄ emm77). A strong
parallel between the data reported here and a
study of macrolide-resistant S. pyogenes isolates
recovered in Belgium during a similar period was
also noted. Although only data concerning PFGE
clustering, emm type and macrolide resistance
phenotype and genotype are available for com-
parison, the major clones identified in Belgium
seem to correspond to those found in Portugal.
Two PFGE clusters, containing emm22 and emm28
isolates, respectively, accounted for the majority of
erm(B) isolates, and two PFGE clusters, containing
emm1 and emm4 isolates, respectively, accounted
for the majority of mef(A) isolates [8]. This strong
similarity existed despite an overall lower level of
macrolide resistance in Belgium and the temporal
variations in the prevalence of the different phe-
notypes compared with Portugal [4,8].
These observations argue in favour of Europe-
wide dissemination of a limited number of
macrolide-resistant clones, although each country
may retain specificity regarding the prevalence of
the different genotypes and clones. It is currently
unclear whether these resistant clones are spread-
ing throughout Europe, or whether they result
from independent acquisition of resistance genes
by the same prevalent STs, followed by local
dissemination. Whenever these clones account for
the majority of macrolide-resistant isolates, they
frequently share the same resistance determi-
nants, regardless of the country of origin, sug-
gesting geographical dissemination. Nevertheless,
local acquisition of resistance genes must also
play a role, since isolates fully susceptible to
macrolides that share the same STs as these major
clones have been described [23], and either of the
resistant determinants has been associated with
each lineage, both in the present report and in
previous studies [3,10]. This hypothesis is further
supported by previous observations showing that
conjugal transfer of elements carrying either the
erm or the mef(A) resistance determinants among
S. pyogenes can occur in vitro [24]. The alterations
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in the prevalence of macrolide resistance differ
significantly among different European countries
and cannot be correlated directly with use of
macrolides [4,8]. As expected, a situation in which
macrolide resistance is changing can be accom-
panied by changes in the prevalent clones [8], but
such changes can also occur when macrolide
resistance is stable [4], suggesting that other
factors, such as natural fluctuations in the preval-
ence of clones [6], may be important determinants
of macrolide resistance and the associated pheno-
types.
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